It is a pharma private limited company based in Gandhinagar, Gujarat, India, established in 2022.
2022 | Gandhinagar, Gujarat, India | ActiveNuramed Pharmaceuticals Private Limited, a active private limited company, was established on 14 October 2022 in Gandhinagar, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290GJ2022PTC136185. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹4.00 Cr.
It upholds a compliant status. Employing 12 professional, Its leadership includes Nitin Rammilan Tiwari (Director), Pradeep Kumar Sahal (Director). It holds ₹47.28 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at House No. 24, Siddhi Vinayak Bungalows Sargasan Cross Road, Sargasan, Gandhinagar, Gujarat, 382421.
U24290GJ2022PTC136185
136185
14 October 2022
₹9.00 Cr
₹4.00 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Nuramed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Rammilan Tiwari | Director | 14 Oct 2022 | Current |
| Pradeep Kumar Sahal | Director | 14 Oct 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nuramed Pharmaceuticals Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Nuramed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹472,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2025 | Others | ₹2.50 Cr | Open |
| 22 Sep 2023 | Others | ₹16.10 Cr | Open |
| 20 Sep 2023 | Others | ₹28.68 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nuramed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nuramed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuramed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nuramed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
A charge with Others of Rs. 28.68 Cr registered on 20 Sep 2023 with Charge ID 100795459 was modified on 04 Sep 2025. was recorded as a recent event.
The activity Nuramed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
Progress on A charge with Others amounted to Rs. 2.50 Cr with Charge ID 101039336 was registered on 28 Jan 2025. was documented.
Progress on A charge with Others of Rs. 16.10 Cr registered on 22 Sep 2023 with Charge ID 100795457 was modified on 25 Sep 2024. was documented.
The activity A charge with Others amounted to Rs. 16.10 Cr with Charge ID 100795457 was registered on 22 Sep 2023. was completed.
The CIN of Nuramed Pharmaceuticals Private Limited is U24290GJ2022PTC136185.
Nuramed Pharmaceuticals Private Limited is headquartered at House No. 24, Siddhi Vinayak Bungalows Sargasan Cross Road, Sargasan, Gandhinagar, Gujarat, 382421.
Nuramed Pharmaceuticals Private Limited was incorporated on 14 October 2022.
The current directors of Nuramed Pharmaceuticals Private Limited are
The primary industry of Nuramed Pharmaceuticals Private Limited is Pharma.
Nuramed Pharmaceuticals Private Limited is unlisted.
The authorized capital of Nuramed Pharmaceuticals Private Limited is ₹9.00 Cr, and the paid-up capital is ₹4.00 Cr.
The compliance status of Nuramed Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX